| 2006P-0346 | Ban Marketing of Estratest, Estratest H.S. and Syntest D.S. and Syntest H.S. associated with Menopause | |||||||||||||||||||||||
| FDA Comment Number : | EC1 | |||||||||||||||||||||||
| Submitter : | Mr. Dave Lowe | Date & Time: | 09/05/2006 10:09:44 | |||||||||||||||||||||
| Organization : | Mr. Dave Lowe | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I support the petition in part. Banning marketing on Estratest, Estratest H.S. and Syntest D.S. and Syntest H.S. is a start. There are others.
A Self explanatory attachment of a prescription drug ad with CFR is included. Remove Kadian as misbranded, withdrawing any paper NDA's that may or may not exist making that a legal approval. | ||||||||||||||||||||||||